Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
107.00
+3.00 (2.88%)
At close: Feb 10, 2026
Market Cap24.72B -17.9%
Revenue (ttm)11.58B +23.1%
Net Income570.05M -13.9%
EPS2.47 -13.9%
Shares Out231.00M
PE Ratio43.36
Forward PEn/a
Dividend2.10 (1.96%)
Ex-Dividend DateNov 17, 2025
Volume338,092
Average Volume277,282
Open105.00
Previous Close104.00
Day's Range105.00 - 107.50
52-Week Range92.40 - 147.50
Beta-0.63
RSI56.43
Earnings DateJan 28, 2026

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointesti... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 4,162
Stock Exchange Dhaka Stock Exchange
Ticker Symbol BEACONPHAR
Full Company Profile

Financial Performance

In fiscal year 2024, Beacon Pharmaceuticals's revenue was 10.70 billion, an increase of 25.76% compared to the previous year's 8.51 billion. Earnings were 521.01 million, an increase of 2.19%.

Financial Statements